Case for stopping targeted therapy when lung cancer progresses on treatment in hospice- eligible patients

Thomas J. Smith, Nasser Hanna, David Johnson, Sherman Baker, William A. Biermann, Julie Brahmer, Peter M. Ellis, Giuseppe Giaccone, Paul J. Hesketh, Ishmael Jaiyesimi, Natasha B. Leighl, Gregory J. Riely, Joan H. Schiller, Bryan J. Schneider, Joan Tashbar, Sarah Temin, Gregory Masters

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)780-783
Number of pages4
JournalJournal of Oncology Practice
Volume13
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Hospices
Lung Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Case for stopping targeted therapy when lung cancer progresses on treatment in hospice- eligible patients. / Smith, Thomas J.; Hanna, Nasser; Johnson, David; Baker, Sherman; Biermann, William A.; Brahmer, Julie; Ellis, Peter M.; Giaccone, Giuseppe; Hesketh, Paul J.; Jaiyesimi, Ishmael; Leighl, Natasha B.; Riely, Gregory J.; Schiller, Joan H.; Schneider, Bryan J.; Tashbar, Joan; Temin, Sarah; Masters, Gregory.

In: Journal of Oncology Practice, Vol. 13, No. 12, 01.12.2017, p. 780-783.

Research output: Contribution to journalReview article

Smith, TJ, Hanna, N, Johnson, D, Baker, S, Biermann, WA, Brahmer, J, Ellis, PM, Giaccone, G, Hesketh, PJ, Jaiyesimi, I, Leighl, NB, Riely, GJ, Schiller, JH, Schneider, BJ, Tashbar, J, Temin, S & Masters, G 2017, 'Case for stopping targeted therapy when lung cancer progresses on treatment in hospice- eligible patients', Journal of Oncology Practice, vol. 13, no. 12, pp. 780-783. https://doi.org/10.1200/JOP.2017.027367
Smith, Thomas J. ; Hanna, Nasser ; Johnson, David ; Baker, Sherman ; Biermann, William A. ; Brahmer, Julie ; Ellis, Peter M. ; Giaccone, Giuseppe ; Hesketh, Paul J. ; Jaiyesimi, Ishmael ; Leighl, Natasha B. ; Riely, Gregory J. ; Schiller, Joan H. ; Schneider, Bryan J. ; Tashbar, Joan ; Temin, Sarah ; Masters, Gregory. / Case for stopping targeted therapy when lung cancer progresses on treatment in hospice- eligible patients. In: Journal of Oncology Practice. 2017 ; Vol. 13, No. 12. pp. 780-783.
@article{f452b7792f3343d0b3102a722b14fc56,
title = "Case for stopping targeted therapy when lung cancer progresses on treatment in hospice- eligible patients",
author = "Smith, {Thomas J.} and Nasser Hanna and David Johnson and Sherman Baker and Biermann, {William A.} and Julie Brahmer and Ellis, {Peter M.} and Giuseppe Giaccone and Hesketh, {Paul J.} and Ishmael Jaiyesimi and Leighl, {Natasha B.} and Riely, {Gregory J.} and Schiller, {Joan H.} and Schneider, {Bryan J.} and Joan Tashbar and Sarah Temin and Gregory Masters",
year = "2017",
month = "12",
day = "1",
doi = "10.1200/JOP.2017.027367",
language = "English (US)",
volume = "13",
pages = "780--783",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "12",

}

TY - JOUR

T1 - Case for stopping targeted therapy when lung cancer progresses on treatment in hospice- eligible patients

AU - Smith, Thomas J.

AU - Hanna, Nasser

AU - Johnson, David

AU - Baker, Sherman

AU - Biermann, William A.

AU - Brahmer, Julie

AU - Ellis, Peter M.

AU - Giaccone, Giuseppe

AU - Hesketh, Paul J.

AU - Jaiyesimi, Ishmael

AU - Leighl, Natasha B.

AU - Riely, Gregory J.

AU - Schiller, Joan H.

AU - Schneider, Bryan J.

AU - Tashbar, Joan

AU - Temin, Sarah

AU - Masters, Gregory

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85039963882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039963882&partnerID=8YFLogxK

U2 - 10.1200/JOP.2017.027367

DO - 10.1200/JOP.2017.027367

M3 - Review article

VL - 13

SP - 780

EP - 783

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 12

ER -